1.The clinical characteristics of pulmonary alveolar proteinosis: experience at Seoul National University Hospital, and review of the literature.
Gyesu KIM ; Seung Joon LEE ; Hyuk Pyo LEE ; Chul Gyu YOO ; Sung Koo HAN ; Young Soo SHIM ; Young Whan KIM
Journal of Korean Medical Science 1999;14(2):159-164
Pulmonary alveolar proteinosis is such an extremely rare disease in Korea, that only a few cases have been reported. Meanwhile five cases were experienced at Seoul National University Hospital over ten years since 1987. We summarized the clinical characteristics and courses of them. Seven cases reported in the literature were included to add data about clinical characteristics and courses although only a few case reports mentioned patient's course. Middle aged male patients were mainly affected. No association with particular environmental or occupational exposure was identified. Dyspnea on exertion was the main symptom. Bilateral crackles were consistent, and bilateral parahilar hazy infiltrations on plain chest radiograph and ground glass opacity on high-resolution CT were characteristic. Superimposed infection was not identified in any patient at the time of diagnosis. Decreased diffusing capacity and hypoxia were present in almost every case. Whole lung lavage proved to be an effective therapeutic measure. The response to treatment was good. Long-term course of the disease, e.g. recurrence rate, is not yet known.
Adult
;
Age Distribution
;
Aged
;
Female
;
Hospitals, Public*
;
Hospitals, University*
;
Human
;
Korea
;
Male
;
Middle Age
;
Pulmonary Alveolar Proteinosis/therapy
;
Pulmonary Alveolar Proteinosis/radiography
;
Pulmonary Alveolar Proteinosis/physiopathology*
;
Pulmonary Alveolar Proteinosis/diagnosis
;
Sex Distribution
;
Smoking/adverse effects
2.Clinical Features and Outcomes of Idiopathic Pulmonary Alveolar Proteinosis in Korean Population.
Min Kwang BYUN ; Dong Soon KIM ; Young Whan KIM ; Man Pyo CHUNG ; Jae Jeong SHIM ; Seung Ick CHA ; Soo Taek UH ; Choon Sik PARK ; Sung Hwan JEONG ; Yong Bum PARK ; Hong Lyeol LEE ; Moo Suk PARK
Journal of Korean Medical Science 2010;25(3):393-398
Idiopathic pulmonary alveolar proteinosis (PAP) is a rare disorder in which lipoproteinaceous material accumulates within alveoli. There were few reports on Asian populations with idiopathic PAP. We retrospectively reviewed 38 patients with idiopathic PAP in Korea. We assessed clinical features, therapeutic efficacy and outcomes of whole lung lavage in patients with idiopathic PAP. The mean age at diagnosis was 52 yr. Eighty six percent of patients were symptomatic at diagnosis. Dyspnea and cough were the most common symptoms. Crackles were the most common physical examination finding. On pulmonary function test, a mild restrictive ventilatory defect was common, with a predicted mean forced vital capacity (FVC) of 77% and forced expiratory volume in one second (FEV1) of 84.6%. Diffusing capacity was disproportionately reduced at 67.7%. Arterial blood gas analysis revealed hypoxemia with a decreased PaO2 of 69.0 mmHg and an increased D(A-a)O2 of 34.2 mmHg. After whole lung lavage, PaO2, D(A-a)O2 and DLCO were significantly improved, but FVC and total lung capacity (TLC) were not different. This is the first multicenter study to analyze 38 Korean patients with idiopathic PAP. The clinical features and pulmonary parameters of Korean patients with idiopathic PAP are consistent with reports in other published studies. Whole lung lavage appears to be the most effective form of treatment.
Adult
;
Biopsy
;
Bronchoalveolar Lavage
;
Female
;
Humans
;
Korea
;
Male
;
Middle Aged
;
Pulmonary Alveolar Proteinosis/diagnosis/pathology/*physiopathology/*therapy
;
Respiratory Function Tests
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome
3.Characteristics of serum lipid metabolism in patients with autoimmune pulmonary alveolar proteinosis.
Yan LI ; Xin-Lun TIAN ; Yao-Song GUI ; Ai-Ping MA ; Xue LI ; Ni ZENG ; Peng ZHANG ; Yong-Zhong ZHAN ; Guo-Zhen LI ; Kai-Feng XU
Acta Academiae Medicinae Sinicae 2014;36(6):645-649
OBJECTIVETo study the serum lipid panels in consecutive autoimmune pulmonary alveolar proteinosis(APAP)patients and analyze their relationship with anti-granulocyte macrophage-colony stimulating factor(GM-CSF)antibody and other markers.
METHODSThirty-two non-diabetic APAP patients were enrolled in the study. Serum lipids of these patients and 100 healthy volunteers were tested after an overnight fasting. Anti-GM-CSF antibody levels were measured with enzyme-linked immunosorbent assay. The correlation of serum lipids with lactate dehydrogenase,carcinoembryonic antigen,pulmonary function,and artery blood gas parameters were analyzed.
RESULTSTotal cholesterol and low-density lipoprotein cholesterol levels [(5.54±0.99)and(3.73±0.83)mmol/L respectively] were significantly higher in APAP patients than in healthy volunteers [(5.05±0.97)and(3.17±0.89)mmol/L respectively](all P<0.05). High-density lipoprotein cholesterol(HDL-C)level of the APAP group [(1.10±0.18)mmol/L ]was significantly lower than that of the healthy group(P<0.05). Low-density lipoprotein/HDL and total cholesterol/HDL ratios in the APAP group(3.47±0.90 and 5.14±1.12 respectively)were significantly higher than those in the healthy group[(2.63±0.87)and(4.18±1.12)](all P<0.05). There was no significant difference in triglyceride level between the two groups(P>0.05). HDL-C level was negatively correlated with alveolar-arterial oxygen pressure difference(r=-0.436,P<0.05)and positively correlated with arterial oxygen saturation(r=0.459,P<0.05). None of the lipid markers correlated with serum anti-GM-CSF antibody levels(all P>0.05).
CONCLUSIONSAPAP patients were likely to suffer from disturbed lipid metabolism,which was correlated with disease severity to some degree. Lipid markers deserved more attention in the management of APAP patients.
Antibodies ; blood ; Autoimmune Diseases ; epidemiology ; metabolism ; Biomarkers ; blood ; Cholesterol ; blood ; Enzyme-Linked Immunosorbent Assay ; Granulocyte-Macrophage Colony-Stimulating Factor ; metabolism ; Humans ; Lipid Metabolism ; Lipids ; blood ; Lipoproteins, LDL ; blood ; Lung ; physiopathology ; Pulmonary Alveolar Proteinosis ; epidemiology ; metabolism